In conclusion, our findings using a novel transgenic mouse with cardiomyocyte-specific expression of Myc (MHC-Myc mice) clearly demonstrate that increased expression of Myc can induce hypertrophic cardiomyopathy and heart failure in vivo. The gene discussed is HLA-C; the disease is heart failure.